Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of OsteoBor in Postmenopausal Osteoporosis: A Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial

NCT06809816 is registered in ClinicalTrials.gov with Tabriz University of Medical Sciences as lead sponsor.

NCT NCT06809816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06809816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of OsteoBor in Postmenopausal Osteoporosis: A Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial
Lead sponsor
Tabriz University of Medical Sciences
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
September 1, 2025
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis, postmenopausal